Shortening the Washout to 4 Weeks when Switching from Natalizumab to Fingolimod and Risk of Disease Reactivation in Multiple Sclerosis

CONCLUSIONSOur study suggests that switching from natalizumab to fingolimod with a shorter washout of 4 weeks might reduce the risk of disease reactivation after switching.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research